Note - The product information found within this database originates from organizations not subject to the Official Languages Act and is available in the language in which it was written and submitted to Health Canada.

Note - The market status of a product is now available in the LNHPD and identifies if a product is "marketed" or "not marketed" in Canada. Product licence holders may voluntarily provide the Natural and Non-Prescription Health Products Directorate (NNHPD) with information about whether their product is currently available to Canadian consumers. Where no information has been provided, the default status is "not marketed". The "current status" field remains unaffected and will continue to indicate the status of the product licence (i.e., active, discontinued, stop sale, cancelled, or suspended). Note that where a licence has been suspended, cancelled or under stop sale, the product cannot be legally sold in Canada.

Product licence holders - if you wish to update a product's market status, you are invited to complete the Natural Health Products Market Notification Web Form. As with all other notifications, there is no current service standard. The NNHPD will process the market status update as soon as feasible, based on its available resources. As a reminder, market notification is voluntary; therefore, a licence holder is not required to wait for the LNHPD to be updated before a licensed product is sold in Canada. As such, products that are identified in the LNHPD as "not marketed" may still be sold in Canada.

New search

Natural Product Number (NPN):

80074298

Market status:

Not Marketed

Licence Status:

Active

Brand name(s):

Ki Kids Cough & Cold Liquid ;
Ki Cough & Cold ;
Ki Cough & Cold Liquid ;
Ki Kids Cough & Cold

Licence holder:

Martin & Pleasance Pty Ltd.

Dosage Form:

Liquid

Recommended route of administration:

Oral

Recommended use or purpose:

Supportive therapy in the treatment of upper respiratory tract infections (e.g. common colds). Helps to relieve the symptoms and shorten the duration of upper respiratory tract infections. Echinacea is used in Herbal Medicine to help fight off infections, especially of the upper respiratory tract. Echinacea is traditionally used in Herbal Medicine to help relieve cold symptoms. Licorice and Ivy leaf are traditionally used in herbal medicine as expectorants to help relieve coughs. Licorice is traditionally used in Herbal Medicine as an expectorant to help relieve chest complaints, such as catarrhs, coughs and bronchitis.

Risk Information:

Cautions and Warnings 

Not to be used in children under 4 years of age without medical advice. If symptoms or coughing persist or worsen consult your healthcare practitioner. Consult a health care practitioner prior to use if you are pregnant, taking immunosuppressants, or antitussives (e.g. codeine or dextromethorphan), or have a liver disorder, an autoimmune disorder, gastrointestinal inflammation, or ulcer or a progressive systemic disease such as tuberculosis, collagenosis, multiple sclerosis, AIDS and/or HIV infection. Gastrointestinal discomfort (e.g. nausea, vomiting, and diarrhea) has been known to occur, in which case discontinue use.

Contra-Indications 

Do not use if you are taking thiazide diuretics, cardiac glycosides, corticosteroids, stimulant laxatives or other medications which may aggravate electrolyte imbalance, or if you have hypokalemia, high blood pressure, or a kidney or cardiovascular disorder.

Known Adverse Reactions 

Rare cases of severe allergic reactions have been known to occur; use caution if you are allergic to plants of the Daisy family.

List of medicinal ingredients:

Medicinal ingredients	Quantity (Qty)	Extract	Potency
Echinacea purpurea	4.444 mg/ml
Glycyrrhiza glabra	5.555 mg/ml	9.001 : 1.0 DHE: 50.0 mg Dry
Hedera helix	1.25 mg/ml	8.0 : 1.0 DHE: 10.0 mg Dry
Lonicera japonica	10.0 mg/ml	20.0 : 1.0 DHE: 200.0 mg Dry

List of non-medicinal ingredients:

• Aqua
• Berry flavour
• Citric acid monohydrate
• Dextrin
• Glycerin
• Potassium sorbate
• Sodium hydroxide
• Sorbitol Solution
• beta-Cyclodextrin

Date of licensing:

2016-12-08

Revised date of licence:

2023-08-29